FDA approves first new non-opioid pain pill in 20 years—how it works
The FDA has approved Journavx, a new non-opioid pain medication designed to reduce addiction and overdose risks.
FDA Approves First New Non-Opioid Pain Pill in Decades
FRIDAY, Jan. 31, 2025 (HealthDay News) -- The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain ...
Colorado drug bust uncovers cartel-connected illegal aliens, approximately 130k fentanyl pills
Two illegal aliens tied to Mexican cartels and approximately 130,000 fentanyl pills, heroin, cocaine and meth were discovered ...
At $31 a day, is Vertex’s new non-addictive painkiller worth the price?
Will people with acute pain want a new painkiller whose list price is $15.50 a pill when a generic prescription drug is at ...
Khaleej Times5h
Dubai: Man sentenced to life for drug trafficking, trying to sell 1,305 Methadone pills
The police obtained permission from the public prosecution to conduct a sting operation and arrest the defendant red handed ...
FDA approves Journavx, the first new painkiller in over two decades
The new drug will carry a list price of $15.50 per pill, making it many times more expensive than comparable opioids.
CBS News on MSN15d
Medicare drug price negotiations to target Ozempic, Wegovy and other drugs
The hugely popular medications Ozempic and Wegovy​, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.
WISH-TV on MSN1d
FDA approves new pain pill with potential to curb opioid addiction
The FDA has approved Vertex Pharmaceuticals' Journavx, a new pain medication that doesn't carry the risks of addiction and ...
US drug regulator approves first new type of pain pill in more than 20 years
The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain ...
Billed as nonaddictive, new pain pill could soon win FDA approval
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove safe and effective for chronic pain.